CSPIA
IONS icon

Cary Street Partners Investment Advisory’s Ionis Pharmaceuticals IONS Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$5K – 602
2020
Q3 		$5K Buy
+100
New +$5.55K ﹤0.01% 839

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Cary Street Partners Investment Advisory's IONS Position: Q4 2020 in Review

Cary Street Partners Investment Advisory sold out of Ionis Pharmaceuticals (IONS) in Q4 2020, closing a stake of 100 shares — an estimated $5K sold.

Cary Street Partners Investment Advisory first reported a position in IONS in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 383 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

  • Cary Street Partners Investment Advisory reported no remaining Ionis Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 100 Ionis Pharmaceuticals shares in Q4 2020, an estimated $5K.
  • Cary Street Partners Investment Advisory first reported a position in Ionis Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Cary Street Partners Investment Advisory's Ionis Pharmaceuticals position peaked at $5K in Q3 2020.
  • 383 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.